Haplotype synthesis analysis reveals functional variants underlying known genome-wide associated susceptibility loci

Bioinformatics

Volumn 32, Issue 14, 2016, Pages 2136-2142

  Lacour, André ^a   Ellinghaus, David ^b   Schreiber, Stefan ^b   Franke, Andre ^b   Becker, Tim ^c  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPUTATIONAL BIOLOGY; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84992389431     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btw125     Document Type: Article

References (33)

1. 1000 Genomes Project Consortium. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature, 491, 56-65.
2. Anderson, C.A. et al. (2011) Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol., 9, e1000580.
3. Atwell, S. et al. (2010) Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines. Nature, 465, 627-631.
4. Becker, T. and Knapp, M. (2004) Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet. Epidemiol., 27, 21-32.
5. Burdett, T (EBI). et al. (2012) The NHGRI-EBI Catalog of published genome-wide association studies. Version v1.0. Available at: http://www.ebi.ac.uk/gwas (10 January 2016, date last accessed).
6. Bush, W.S. and Moore, J.H. (2012) Chapter 11: genome-wide association studies. PLoS Comput. Biol., 8, e1002822.
7. Chang, D. and Keinan, A. (2012) Predicting signatures of "synthetic associations" and "natural associations" from empirical patterns of human genetic variation. PLoS Comput. Biol., 8, e1002600.
8. Chang, C.C. et al. (2015) Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience, 4, 7.
9. Deleneau, S.P. et al. (2013) Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods, 10, 5-6.
10. Dickson, S.P. et al. (2010) Rare variants create synthetic genome-wide associations. PLoS Biol., 8, e1000294.
11. Edge, M.D. et al. (2013) Windfalls and pitfalls: applications of population genetics to the search for disease genes. Evol. Med. Public Health, 254-272.
12. Excoffier, L. and Slatkin, M. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
13. Fellay, J. et al. (2010) ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature, 464, 405-408.
14. Franke, A. et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's Disease susceptibility loci. Nat. Genet., 42, 1118-1125.
15. Goldstein, D.B. (2009) Common genetic variation and human traits. N. Engl. J. Med., 360, 1696-1608.
16. Goldstein, D.B. (2011) The importance of synthetic associations will only be resolved empirically. PLoS Biol., 9, e1001008.
17. Hirschhorn, J.N. and Daly, M.J. (2005) Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet., 6, 95-108.
18. Jostins, L. et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 1, 119-124.
19. Kumar, V. et al. (2013) Genome-wide association study signal at the 12q12 locus for Crohn's Disease may represent associations with the MUC19 gene. Inflamm. Bowel Dis., 19, 1254-1259.
20. Krawczak, M. et al. (2006) PopGen: population based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Commun. Genet., 9, 55-61.
21. Long, J.C. et al. (1995) An E-M algorithm and testing strategy for multiplelocus haplotypes. Am. J. Hum. Genet., 56, 799-810.
22. Mahajan, A. et al. (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type2 diabetes susceptibility. Nat. Genet., 46, 234-244.
23. Marian, A.J. (2012) Molecular genetic studies of complex phenotypes. Transl. Res., 159, 64-79.
24. McCarthy, S. (2015) A reference panel of 64,976 haplotypes for genotype imputation. BioRXiv: Preprint Server Biol., 1-24.
25. Orozco, G. et al. (2010) Synthetic associations in the context of genome-wide association scan signals. Hum. Mol. Genet., 19, R137-R144.
26. Platt, A. et al. (2010) Conditions under which genome-wide association studies will be positively misleading. Genetics, 186, 1045-1052.
27. Purcell, S. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
28. Scherag, A. et al. (2010) Investigation of a genome wide association signal for obesity: synthetic association and haplotype analyses at the melanocortin 4 receptor gene locus. PLoS One, 5, e13967.
29. Takeuchi, F. et al. (2009) A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet., 5, e1000433.
30. Takeuchi, F. et al. (2011) Detection of common single nucleotide polymorphisms synthesizing quantitative trait association of rarer causal variants. Genome Res., 21, 1122-1130.
31. Wadelius, M. et al. (2007) Association of warfarin dose with genes involved in its action and metabolism. Hum. Genet., 121, 23-34.
32. Wang, K. et al. (2010) Interpretation of association signals and identification of causal variants from genome-wide association studies. Am. J. Hum. Genet., 86, 730-742.
33. Wray, N.R. et al. (2011) Synthetic associations created by rare variants do not explain mostGWAS results. PLoS Biol., 9, e1000579.